Haematology: clinical-trial pipeline
11,099 haematology trials are in ClinicalTrials.gov and the EU CTIS portal; 2,534 are not yet finished and 332 of those are in phase 2/3 or 3. Source: Arcadium Data, data as of .
Open trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 1,153 |
| Phase 2 | 464 |
| Phase 3 | 288 |
| Phase 1 | 209 |
| Phase 1/2 | 198 |
| Phase 4 | 129 |
| Early phase 1 | 49 |
| Phase 2/3 | 44 |
Sponsors with the most open trials
Recently changed open trials
| Registry id | Title | Sponsor | Phase | Status | Countries |
|---|---|---|---|---|---|
| 2024-511651-17-00 | A phase II multicenter single-armed study using subject-specific minimal residual minimal disease markers to… | Karolinska University Hospital | Phase 2 | Recruiting | Denmark, Finland, Norway, Sweden |
| 2023-509019-97-00 | HEAT-AML (Hydroxyurea-Enhanced Ara-C Treatment of Adult Acute Myeloid Leukaemia): A phase I/II multi-centre s… | Karolinska University Hospital | Phase 1/2 | Active, not recruiting | Sweden |
| NCT06093672 | Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera | Italfarmaco | Phase 3 | Recruiting | Austria, Bulgaria, Germany, Spain +11 |
| 2023-508212-38-00 | TALTEC: A phase II study measuring MRD negativity after bispecific T-cell redirectors TALquetamab and TEClist… | North Estonia Medical Centre Foundation | Phase 2 | Active, not recruiting | Denmark, Estonia, Norway |
| NCT04657822 | Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizu… | Novartis Pharmaceuticals | Phase 4 | Active, not recruiting | Belgium, Brazil, Colombia, Germany +6 |
| NCT03793478 | Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer o… | Daiichi Sankyo | Phase 1/2 | Active, not recruiting | Belgium, Canada, Denmark, Spain +6 |
| NCT06716814 | Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Al… | Swedish Orphan Biovitrum | Phase 3 | Active, not recruiting | Bulgaria, Germany, Spain, France +6 |
| NCT06523959 | Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial | Clinical Urology and Epidemiology Working Group | Phase 4 | Recruiting | Finland |
| NCT06252870 | Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate… | Nantes University Hospital | Phase 2 | Recruiting | France |
| NCT05317416 | Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant | Pfizer | Phase 3 | Active, not recruiting | Austria, Australia, Belgium, Brazil +22 |
| 2024-512731-74-00 | Venetoclax and Dexamethasone in translocation (11;14) positive relapsed and refractory multiple myeloma (VICT… | Lillebaelt Hospital | Phase 2 | Active, not recruiting | Denmark |
| 2023-506705-20-00 | CARMOD - Golcadomide (BMS-986369) post-CAR T-cell in R/R Aggressive large B-cell lymphoma patients with high… | Lymphoma Academic Research Organisation | Phase 2 | Recruiting | France |
| NCT06379789 | A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV13… | Regeneron Pharmaceuticals | Phase 1/2 | Recruiting | Australia, Brazil, Canada, Germany +5 |
| NCT03937154 | Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Can… | Amgen | Phase 3 | Active, not recruiting | Argentina, Brazil, Spain, Greece +6 |
| 2023-510316-39-00 | AML-VAC-XS15-01: Multi-peptide vaccination adjuvanted with the TLR1/2 ligand XS15 in acute myeloid leukemia (… | Universitaetsklinikum Tuebingen AöR | Phase 1 | Recruiting | Germany |
| 2023-508420-36-00 | Phase I clinical trial on the use of fresh, allogeneic, second-generation CD19-CAR T cells for treatment of c… | Ospedale Pediatrico Bambino Gesu' | Phase 1 | Recruiting | Italy |
| 2023-508355-39-00 | Phase I/II study of anti-CD7 Chimeric Antigen Receptor-Expressing T cells in pediatric patients/young adult a… | Ospedale Pediatrico Bambino Gesu' | Phase 1/2 | Recruiting | Italy |
| NCT06926205 | CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Gr… | GELLC (Grupo Español de Leucemia Linfocítica Crónica) | Phase 2 | Active, not recruiting | Spain |
| NCT05254743 | A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/… | Loxo Oncology, Inc. | Phase 3 | Recruiting | Argentina, Austria, Australia, Belgium +18 |
| NCT04077307 | A Study in Leukemia Patients With Karonudib | Thomas Helleday Foundation | Phase 1 | Recruiting | Denmark, Serbia, Sweden |
All areas: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Haematology clinical trials: 2,534 open, 332 in phase 3", https://arcadiumdata.io/clinical-trials/area/haematology/, data as of 2026-10-25.